Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Iyad Sultan is active.

Publication


Featured researches published by Iyad Sultan.


Cancer | 2009

Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database.

Ibrahim Qaddoumi; Iyad Sultan; Amar Gajjar

Pediatric gliomas are rare and heterogeneous tumors. The Surveillance, Epidemiology, and End Results (SEER) database allows a large‐scale analysis of the clinical characteristics and prognostic features of these tumors.


Cancer | 2009

Comparing children and adults with synovial sarcoma in the surveillance, epidemiology, and end results program, 1983 to 2005: An analysis of 1268 patients

Iyad Sultan; Carlos Rodriguez-Galindo; Raya Saab; Sameer Yasir; Michela Casanova; Andrea Ferrari

Synovial sarcoma (SS) is a typical soft tissue sarcoma subtype crosswise between the pediatric and the adult age groups. Less satisfactory overall outcome has been recorded in adult series.


Pediatric Blood & Cancer | 2011

Soft Tissue Sarcoma Across the Age Spectrum: A Population-Based Study from the Surveillance Epidemiology and End Results Database

Andrea Ferrari; Iyad Sultan; Tseng Tien Huang; Carlos Rodriguez-Galindo; Ahmad Shehadeh; Cristina Meazza; Kirsten K. Ness; Michela Casanova; Sheri L. Spunt

Soft tissue sarcomas (STS) are a heterogeneous group of mesenchymal malignancies that occur throughout the lifespan. The impact of age on disease features and outcome is unclear.


British Journal of Ophthalmology | 2010

Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators

Serife Canturk; Ibrahim Qaddoumi; Vikas Khetan; Zhigui Ma; A. Furmanchuk; Célia Beatriz Gianotti Antoneli; Iyad Sultan; Rejin Kebudi; Tarun Sharma; Carlos Rodriguez-Galindo; David H. Abramson; Guillermo Chantada

Background The survival of retinoblastoma in less-developed countries (LDCs) and the impact of socioeconomic variables on survival are not widely available in the literature. Methods A systematic review of publications from LDCs was performed. Articles were from multiple databases and written in seven languages. Results were correlated with socioeconomic indicators. Lower-income countries (LICs) and middle-income countries (MICs) were included in our analyses. Results An analysis of 164 publications including 14 800 patients from 48 LDCs was performed. Twenty-six per cent of the papers were written in languages other than English. Estimated survival in LICs was 40% (range, 23–70%); in lower MICs, 77% (range, 60–92%) and in upper MICs, 79% (range, 54–93%; p=0.001).Significant differences were also found in the occurrence of metastasis: in LICs, 32% (range, 12–45); in lower MICs, 12% (range, 3–31) and in upper MICs, 9.5% (range, 3–24; p=0.04). On multivariate analysis, physician density and human development index were significantly associated with survival and metastasis. Maternal mortality rate and per capita health expenditure were significantly associated with treatment refusal. Conclusions Important information from LDCs is not always available in English or in major databases. Indicators of socioeconomic development and maternal and infant health were related with outcome.


Pediatric Blood & Cancer | 2011

Strategies to manage retinoblastoma in developing countries.

Guillermo L. Chantada; Ibrahim Qaddoumi; Serife Canturk; Vikas Khetan; Zhigui Ma; Kahaki Kimani; Baris Yeniad; Iyad Sultan; Rita S. Sitorus; Nurdan Tacyildiz; David H. Abramson

Survival of retinoblastoma is >90% in developed countries but there are significant differences with developing countries in stage at presentation, available treatment options, family compliance, and survival. In low‐income countries (LICs), children present with advanced disease, and the reasons are socioeconomic and cultural. In middle‐income countries (MICs), survival rates are better (>70%), but there is a high prevalence of microscopically disseminated extraocular disease. Programs for eye preservation have been developed, but toxicity‐related mortality is higher. Although effective treatment of microscopically extraocular disease improved the outcome, worldwide survival will be increased only by earlier diagnosis and better treatment adherence. Pediatr Blood Cancer 2011;56:341–348.


Cancer | 2010

Distinct features of colorectal cancer in children and adolescents: a population-based study of 159 cases.

Iyad Sultan; Carlos Rodriguez-Galindo; Hani El-Taani; Guido Pastore; Michela Casanova; Gianfranco Gallino; Andrea Ferrari

Colorectal cancer is exceedingly rare in children and adolescents. Reports from small series indicate that poor prognostic factors are more common in children than in adults, resulting in worse outcome for the pediatric population.


Pediatric Blood & Cancer | 2010

Differential features of nasopharyngeal carcinoma in children and adults: A SEER study†

Iyad Sultan; Michela Casanova; Andrea Ferrari; Rawad Rihani; Carlos Rodriguez-Galindo

Nasopharyngeal carcinoma (NPC) is a rare malignancy in the United States, which is considered a low‐risk country.


Pediatric Blood & Cancer | 2010

Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors

Iyad Sultan; Ibrahim Qaddoumi; Carlos Rodriguez-Galindo; Anwar Al Nassan; Khalil Ghandour; Maysa Al-Hussaini

Malignant rhabdoid tumors (MRTs) are aggressive and often fatal; the Surveillance, Epidemiology, and End Results (SEER) database offers an opportunity to study this rare malignancy.


Leukemia & Lymphoma | 2010

Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 1988–2005: an analysis of 21 734 cases

Faiha Bazzeh; Rawad Rihani; Scott C. Howard; Iyad Sultan

We analyzed data from 18 898 adults (age ≥20 years) and 2836 children/adolescents reported in the Surveillance, Epidemiology and End Results (SEER) database as having Hodgkin lymphoma (HL), diagnosed from 1988 to 2005. The nodular sclerosis subtype was significantly more common in the pediatric age group (76% in children/adolescents vs. 61% in adults, p < 0.001). The mixed cellularity subtype was more prevalent in children <10 years old (22%), but less likely in older children/adolescents (8.5%). Systemic symptoms were reported in 39% of children/adolescents and in 48% of adults (p < 0.001). Children/adolescents had significantly better HL-specific survival than adults (5-year survival rate, 96% ± 0.4% vs.88% ± 0.3%, p < 0.001). Using a Cox proportional-hazards regression model in patients with classical HL, the prognostic factors significantly impacting survival were age, histology, stage, B symptoms, year of diagnosis, and race. The only adverse prognostic factors that were significant when this analysis was restricted to children/adolescents were stage IV disease and the presence of B symptoms. In conclusion, several differences in clinicopathologic features and outcomes were identified between children/adolescents and adults with HL, and this was particularly noted in young children (<10 years).


Seminars in Fetal & Neonatal Medicine | 2012

Neonatal soft tissue sarcomas.

Andrea Ferrari; Daniel Orbach; Iyad Sultan; Michela Casanova; Gianni Bisogno

Soft tissue tumors in very young children pose diagnostic and therapeutic challenges. Vascular tumors are the most prevalent soft tissue neoplasms in the neonatal period. They are generally benign tumors, but may exhibit aggressive behaviour and cause life-threatening complications. Fibroblastic tumors of intermediate prognosis, more prevalent in very young children (especially infantile fibrosarcoma), are locally aggressive. Since metastases are unusual in this group of tumors, complete surgical resection is generally curative. However, these tumors often present a therapeutic challenge because of the location which makes complete surgical resection difficult. Among the malignant soft tissue tumors, rhabdomyosarcoma is most frequent. It is an aggressive high-grade tumor, with local invasiveness and a propensity to metastasize. These tumors respond to chemotherapy and radiotherapy. Neonates with rhabdomyosarcoma seem to have a worse prognosis than in older age groups. This may be a result of inappropriate dosing of chemotherapeutic agents and decreased use of radiation therapy among other factors.

Collaboration


Dive into the Iyad Sultan's collaboration.

Top Co-Authors

Avatar

Andrea Ferrari

University Hospital of Basel

View shared research outputs
Top Co-Authors

Avatar

Maysa Al-Hussaini

King Hussein Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Carlos Rodriguez-Galindo

St. Jude Children's Research Hospital

View shared research outputs
Top Co-Authors

Avatar

Imad Jaradat

King Hussein Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Ibrahim Qaddoumi

St. Jude Children's Research Hospital

View shared research outputs
Top Co-Authors

Avatar

Mustafa Mehyar

King Hussein Medical Center

View shared research outputs
Top Co-Authors

Avatar

Ibrahim Nawaiseh

King Hussein Medical Center

View shared research outputs
Top Co-Authors

Avatar

Khalil Ghandour

King Hussein Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Yacoub A. Yousef

King Hussein Medical Center

View shared research outputs
Top Co-Authors

Avatar

Usama Al-Jumaily

King Hussein Cancer Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge